Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Agenus Community
NasdaqCM:AGEN Community
1
Narratives
written by author
0
Comments
on narratives written by author
14
Fair Values set
on narratives written by author
Create a narrative
Agenus
Popular
Undervalued
Overvalued
Community Investing Ideas
Agenus
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Advanced Immuno-Oncology Therapies Will Reshape Future Cancer Care
Key Takeaways Strong clinical data and regulatory momentum could accelerate product approvals, drive significant market expansion, and improve near-term and long-term earnings potential. Strategic non-dilutive transactions and operational efficiencies bolster financial stability, enabling sustained R&D investment and enhancing margins and profitability prospects.
View narrative
US$6.33
FV
45.8% undervalued
intrinsic discount
4.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
AGEN
AGEN
Agenus
Your Fair Value
US$
Current Price
US$3.43
49.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-240m
310m
2015
2018
2021
2024
2025
2027
2030
Revenue US$171.9m
Earnings US$33.2m
Advanced
Set Fair Value